MSD signs voluntary licensing agreements with five Indian pharma firms for Molnupiravir
The agreements have been signed with Cipla, Dr Reddy’s Laboratories, Emcure Pharmaceuticals, Hetero Labs and Sun Pharmaceutical…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Hetero Labs
GSK Pharma board approves sale of Vemgal facility to Hetero Labs for Rs 180 crores
The transaction is expected to be completed by September 30, 2021
Remdesivir and favipiravir price regulation required to safeguard patients’ interest in India:…
Both drugs have seen a sharp decline in price since the availability of the first generic in India
Experts ask govt to ensure access to remdesivir, raise concerns about supply shortage
Many also allude to an emerging black market for remdesivir in the country through which the drug is being sold at exorbitant…
Cipla to price remdesivir version for COVID-19 under 5,000 rupees
Cipla, in an e-mailed statement, did not provide details on when the treatment, called Cipremi, will be available
Gilead signs Voluntary Licensing Agreements with Cipla, Hetero Labs, Jubilant Lifesciences, Mylan…
Under the licensing agreements, the companies have a right to receive a technology transfer of the Gilead manufacturing process…
Dr Reddy’s halts worldwide supply of ranitidine
USFDA probing into the reported impurity N-nitrosodimethylamine in it at low levels
3 Indian cos receive US FDA nod for 1st generic Abilify to treat mental illnesses
Alembic Pharmaceuticals, Hetero Labs, Teva Pharmaceuticals and Torrent Pharmaceuticals have received FDA approval to market…